IKT
Inhibikase Therapeutics Inc
1.90$
-1.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.2% | +0.0% | +0.0% | 0.0% | 0.0% | +92.7% | +90.9% | -1.9% | -100.0% | – | – | – | |
| – | -5.8% | -56.3% | -42.6% | +382.2% | +5,242.7% | -74.2% | +106.1% | +7.5% | +0.2% | +22.6% | -3.8% | – | |
| – | +76.1% | +22.0% | -118.3% | – | -251.9% | – | -64.8% | -560.1% | – | -112.3% | – | – | |
| – | -92.9% | -100.0% | – | +0.0% | -100.0% | – | -100.0% | – | +0.0% | -100.0% | – | – | |
| – | -112.4% | +56.5% | – | -0.7% | -1,634.4% | – | -53.2% | -392.0% | -99.7% | +81,323.4% | -92.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -197,391.4% | – | +784.0% | -94.4% | +54,685.5% | -100.0% | – | -522.2% | – | -97.3% | -100.5% | – | |
| – | -144.0% | – | – | -396.4% | – | -69.5% | -74.6% | -1,017.7% | – | -188.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.